These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 90126)
1. Delayed hypersensitivity to human encephalitogenic protein as assayed by agarose leucocyte migration in multiple sclerosis patients. Clanet M; Kuhlein E; Rascol A; Abbal M; Ohayon E J Neurol Sci; 1979 Jul; 42(2):203-13. PubMed ID: 90126 [TBL] [Abstract][Full Text] [Related]
2. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. Variable effect of the antigen in a large dose range, with a literature review. Källén B; Nilsson O; Thelin C Acta Neurol Scand; 1977 Jan; 55(1):33-46. PubMed ID: 65893 [TBL] [Abstract][Full Text] [Related]
3. Cell-mediated hypersensitivity in multiple sclerosis and other neurological diseases. Minderhoud JM; Mourik J; Teelken AW Clin Neurol Neurosurg; 1977; 80(1):22-32. PubMed ID: 73438 [TBL] [Abstract][Full Text] [Related]
4. Effect of encephalitogenic protein on the migration in agarose of leucocytes from patients with multiple sclerosis. Correlations with clinical parameters, localization of antigenic determinants, and influence of corticotrophin treatment. Berg O; Bergstrand H; Kllén B; Nilsson O Acta Neurol Scand; 1975 Oct; 52(4):303-18. PubMed ID: 53988 [TBL] [Abstract][Full Text] [Related]
5. [Leukocyte migration inhibition test in multiple sclerosis - results of a migration technic according to Clausen using brain specific antigens]. Lehmitz R; Meyer-Rienecker HJ; Werner H; Eichler R Psychiatr Neurol Med Psychol (Leipz); 1980 Oct; 32(10):577-87. PubMed ID: 6164068 [TBL] [Abstract][Full Text] [Related]
6. Delayed hypersensitivity to myelin antigen in multiple sclerosis investigated with the leucocyte migration method. Strandgaard S; Jorgensen PN Acta Neurol Scand; 1972; 48(2):243-8. PubMed ID: 5035962 [No Abstract] [Full Text] [Related]
7. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis. Ilyas AA; Davison AN J Neurol Sci; 1983 Apr; 59(1):85-95. PubMed ID: 6189970 [TBL] [Abstract][Full Text] [Related]
8. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen. Sorensen TB; Kjaer M Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436 [TBL] [Abstract][Full Text] [Related]
9. Age-related reactivity of lymphocytes from multiple sclerosis patients to myelin basic protein. Wicher V; Olszewski W; Milgrom F Int Arch Allergy Appl Immunol; 1981; 66(2):136-41. PubMed ID: 6169648 [TBL] [Abstract][Full Text] [Related]
10. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction. Källén B; Nilsson O; Thelin C Acta Neurol Scand; 1977 Jan; 55(1):47-56. PubMed ID: 65098 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: sensitization of a myelin basic protein fragment (peptide T) encephalitogenic to primates. A preliminary report. Sheremata W; Eylar EH; Cosgrove JB J Neurol Sci; 1977 Jun; 32(2):255-63. PubMed ID: 69018 [TBL] [Abstract][Full Text] [Related]
12. Leukocyte migration in agarose, a study on multiple sclerosis. Bergstrand H; Källén B; Nilsson O Acta Allergol; 1975 Jul; 30(2-3):150-66. PubMed ID: 50704 [TBL] [Abstract][Full Text] [Related]
13. Effect of encephlitogenic protein. PPD and tetanus toxoid on leukocyte migration in agarose. A study of "cross-reactivity". Källén B; Nilsson O Allergy; 1979 Apr; 34(2):97-102. PubMed ID: 89821 [TBL] [Abstract][Full Text] [Related]
14. The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis. Møller-Larsen A; Haahr S; Hansen HJ J Neuroimmunol; 1987 Jan; 13(3):273-82. PubMed ID: 2432085 [TBL] [Abstract][Full Text] [Related]
15. Direct leukocyte migration inhibition by myelin basic protein in exacerbations of multiple sclerosis. Sheremata W; Triller H; Cosgrove JB; Eylar EH Can Med Assoc J; 1977 May; 116(9):985-8. PubMed ID: 870161 [TBL] [Abstract][Full Text] [Related]
16. Hyperreactivity to myelin basic protein in multiple sclerosis. Eggers AE; Tarmin L; Plank CR; Gamboa ET J Neurol Sci; 1981; 52(2-3):385-90. PubMed ID: 6171620 [TBL] [Abstract][Full Text] [Related]
17. In vitro assessment of delayed hypersensitivity in the human. Inhibition of cell migration from agarose microdroplets. Lavergne JA; Harrington JT J Immunol Methods; 1978; 22(1-2):111-21. PubMed ID: 670720 [TBL] [Abstract][Full Text] [Related]
18. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides in multiple sclerosis. Frick E J Neurol Sci; 1982; 57(1):55-66. PubMed ID: 6185643 [TBL] [Abstract][Full Text] [Related]
19. Optic neuritis and multiple sclerosis. Cell-mediated cytotoxicity by peripheral blood lymphocytes against basic protein of myelin, encephalitogenic peptide, cerebrosides and gangliosides. Frick E Eur Neurol; 1988; 28(3):120-5. PubMed ID: 2454817 [TBL] [Abstract][Full Text] [Related]
20. Effect of basic encephalitogenic protein and some peptides derived from it on the migration in agarose gel of leukocytes from patients with multiple sclerosis, other neurological diseases, or carcinoma. Bergstrand H; Källén B; Nilsson O Acta Neurol Scand; 1974; 50(2):227-47. PubMed ID: 4134200 [No Abstract] [Full Text] [Related] [Next] [New Search]